SGI
ABBV icon

Swan Global Investments’s AbbVie ABBV Stock Holding History

Swan Global Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Sell
1,485
-16
-1% -$3.44K 0.01% 81
2026
Q1 		$326K Buy
1,501
+51
+4% +$11.3K 0.01% 62
2025
Q4 		$331K Buy
1,450
+50
+4% +$11.4K 0.01% 62
2025
Q3 		$324K Buy
+1,400
New +$285K 0.01% 57

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Swan Global Investments's ABBV Position: Q2 2026 in Review

Swan Global Investments reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $3.44K and leaving 1,485 shares worth $374K. The position accounts for 0.01% of the portfolio, ranked #81.

Swan Global Investments first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Swan Global Investments held 1,485 shares of AbbVie worth $374K as of Q2 2026.
  • Swan Global Investments sold 16 AbbVie shares in Q2 2026, an estimated $3.44K.
  • AbbVie made up 0.01% of Swan Global Investments's portfolio in Q2 2026, its #81 holding.
  • Swan Global Investments first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Swan Global Investments's 13F filing for Q2 2026, filed 11 Aug 2026.